ECPR for Refractory Out-Of-Hospital Cardiac Arrest (EROCA)
Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest (EROCA)
Sponsor: Food and Drug Administration (FDA)
A NA clinical study on CPR and Cardiac Arrest, this trial is completed. The trial is conducted by Food and Drug Administration (FDA) and has accumulated 13 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Sep 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Apr 2021 — Sep 2021 [monthly]
Completed NA
-
Jan 2021 — Apr 2021 [monthly]
Completed NA
-
Jul 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Jun 2019 — Jun 2020 [monthly]
Enrolling By Invitation NA
-
Jun 2018 — Jun 2019 [monthly]
Enrolling By Invitation NA
-
Jun 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
May 2017 — Jun 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Food and Drug Administration (FDA)
- National Heart, Lung, and Blood Institute (NHLBI)
- Physio-Control
- University of Michigan
For direct contact, visit the study record on ClinicalTrials.gov .